RI
Insider selling
Robert I Blum sold $472K of Cytokinetics Inc (CYTK) stock
Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 7,500 shares of CYTK stock worth $472K, per an SEC Form 4 filed Oct 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 12, 2026, 1 day before it was made public.
CYTK has moved +0.0% since the trade date, from $62.79 to $62.79 (Oct 12, 2026 close).
- Traded
- Oct 12, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 1 day
- Price since
- +0.0%
- Role
- President & CEO
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.